Essiac® and Flor-Essence® herbal tonics stimulate the in vitro growth of human breast cancer cells
- 212 Downloads
People diagnosed with cancer often self-administer complementary and alternative medicines (CAMs) to supplement their conventional treatments, improve health, or prevent recurrence. Flor-Essence® and Essiac® Herbal Tonics are commercially available complex mixtures of herbal extracts sold as dietary supplements and used by cancer patients based on anecdotal evidence that they can treat or prevent disease. In this study, we evaluated Flor-Essence® and Essiac® for their effects on the growth of human tumor cells in culture.
The effect of Flor-Essence® and Essiac® herbal tonics on cell proliferation was tested in MCF-7, MDA-MB-436, MDA-MB-231, and T47D cancer cells isolated from human breast tumors. Estrogen receptor (ER) dependent activation of a luciferase reporter construct was tested in MCF-7 cells. Specific binding to the ER was tested using an ICI 182,780 competition assay.
Flor-Essence® and Essiac® herbal tonics at 1%, 2%, 4% and 8% stimulated cell proliferation relative to untreated controls in both estrogen receptor positive (MCF-7 and T47D) and estrogen receptor negative (MDA-MB-231 and MDA-MB-436) cell lines. Exposure to the tonics also produced a dose-dependent increase in ER dependent luciferase activity in MCF-7 cells. A 10−7 M concentration of ICI 182,780 inhibited the induction of ER dependent luciferase activity by Flor-Essence® and Essiac®, but did not affect cell proliferation.
Flor-Essence® and Essiac® Herbal Tonics can stimulate the growth of human breast cancer cells through ER mediated as well as ER independent mechanisms of action.
Keywordscell growth stimulation complementary and alternative medicine Essiac® Herbal Tonic estrogen receptor Flor-Essence® Herbal Tonic human breast cancer cells
Unable to display preview. Download preview PDF.
We thank Mark Knize for technical assistance with the HPLC analysis of the tonics. This publication was made possible, in part, by grant number 7IB-0003 from the California Breast Cancer Research Program, grant number R21AT001730-02 from the National Center for Complementary and Alternative Medicine (NCAM) and grant number K22 ES00322–01 from the National Institute of Environmental Health Sciences (NIEHS), NIH. It’s contents are solely the responsibility of the authors and do not necessarily represent the official view of the NCAM, NIEHS, NIH or LLNL. This work was performed under the auspices of the U.S. Department of Energy by the University of California, Lawrence Livermore National Laboratory under contract No. W-7405-Eng-48.
- 7.Richardson M, Sanders T, Tamayo C, Perez C, Palmer J, 2000 Flor-Essence® herbal tonic use in North America: A profile of general consumers and cancer patients Herbalgram 50:40–46Google Scholar
- 12.http://www.mdanderson.org Google Scholar
- 13.Percival J, 1994 The Essiac Handbook2ndRideout Publishing CompanyOrlando, FLGoogle Scholar
- 14.Stainsby M: Keeping hope alive. In: The Vancouver Sun. Vancouver, 1992Google Scholar
- 16.Whitaker J: Should you take Essiac tea against cancer? In: Dr Whitaker’s Newsletter. Vol. 5, 1995 http://www.drwhitaker.com/Google Scholar
- 24.Gaido K, Dohme L, Wang F, Chen I, Blankvoort B, Ramamoorthy K, Safe S, 1998 Comparative estrogenic activity of wine extracts and organochlorine pesticide residues in food Environ Health Perspecti 106(Suppl 6):1347–1351Google Scholar
- 38.Pinheiro JC, Bates DM, 2000 Mixed-effects Models in S and S-PLUS Springer-Verlag New YorkGoogle Scholar
- 39.Benjamini Y, Hochberg Y, 1995 Controlling the false discovery rate: a practical and powerful approach to multiple testing J Royal Stat Soc Ser B (Methodological) 57:289–300Google Scholar
- 50.Lamartiniere CA: Protection against breast cancer with genistein: a component of soy. Am J Clin Nutr. 71(6 Suppl): 1705S-1707S, 2000 (discussion 1708S-1709S)Google Scholar
- 54.Hilakivi-Clarke L, Cho E, Onojafe I, Raygada M, Clarke R, 1999 Maternal exposure to genistein during pregnancy increases carcinogen-induced mammary tumorigenesis in female rat offspring Oncol Reports 6:1089–1095Google Scholar